Walgreens Boots Alliance Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Walgreens Boots Alliance de 68.4% y 3.7% por año respectivamente. Se prevé que el BPA crezca en un 73.5% al año. Se espera que la rentabilidad financiera sea de 19.4% en 3 años.

Información clave

67.6%

Tasa de crecimiento de los beneficios

71.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Consumer Retailing	32.1%
Tasa de crecimiento de los ingresos	3.7%
Rentabilidad financiera futura	18.9%
Cobertura de analistas	Good
Última actualización	09 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

BOVESPA:WGBA34 - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
8/31/2026	157,141	2,163	2,643	4,370	10
8/31/2025	150,805	1,820	2,207	3,977	16
8/31/2024	145,322	-7,156	1,389	3,006	16
2/29/2024	144,597	-6,037	-1,766	101	N/A
11/30/2023	142,406	574	-529	1,484	N/A
8/31/2023	139,081	-3,080	141	2,258	N/A
5/31/2023	136,108	-3,315	-821	1,305	N/A
2/28/2023	133,291	-3,144	982	2,954	N/A
11/30/2022	132,184	-2,964	1,403	3,293	N/A
8/31/2022	132,703	4,337	2,165	3,899	N/A
5/31/2022	134,516	5,111	3,439	5,058	N/A
2/28/2022	135,948	5,926	3,626	5,183	N/A
11/30/2021	134,972	5,965	4,057	5,459	N/A
8/31/2021	132,509	1,994	4,176	5,555	N/A
5/31/2021	128,617	1,972	4,983	6,396	N/A
2/28/2021	124,952	-926	4,195	5,556	N/A
11/30/2020	123,509	-981	4,200	5,618	N/A
8/31/2020	121,982	179	4,110	5,484	N/A
5/31/2020	125,566	519	4,359	5,777	N/A
2/29/2020	129,792	3,339	5,269	6,883	N/A
11/30/2019	132,984	3,628	4,576	6,195	N/A
8/31/2019	120,074	3,816	3,892	5,594	N/A
5/31/2019	136,354	4,817	4,402	6,032	N/A
2/28/2019	136,097	5,133	4,756	6,250	N/A
11/30/2018	134,590	5,326	6,261	7,720	N/A
8/31/2018	131,537	5,024	6,896	8,263	N/A
5/31/2018	128,244	4,314	6,038	7,460	N/A
2/28/2018	124,028	4,134	5,699	7,077	N/A
11/30/2017	120,453	3,845	N/A	7,729	N/A
8/31/2017	118,214	4,078	N/A	7,255	N/A
5/31/2017	116,701	4,306	N/A	7,895	N/A
2/28/2017	116,081	4,247	N/A	8,144	N/A
11/30/2016	116,819	4,117	N/A	7,640	N/A
8/31/2016	117,351	4,173	N/A	7,847	N/A
5/31/2016	117,237	3,169	N/A	6,694	N/A
2/29/2016	116,534	3,368	N/A	6,412	N/A
11/30/2015	112,923	4,480	N/A	5,365	N/A
8/31/2015	103,444	4,220	N/A	5,664	N/A
5/31/2015	93,979	3,973	N/A	5,543	N/A
2/28/2015	84,585	3,385	N/A	4,993	N/A
11/30/2014	77,617	2,059	N/A	4,791	N/A
8/31/2014	76,392	1,932	N/A	3,893	N/A
5/31/2014	75,276	2,810	N/A	3,632	N/A
2/28/2014	74,188	2,720	N/A	3,739	N/A
11/30/2013	73,230	2,760	N/A	3,833	N/A
8/31/2013	72,217	2,548	N/A	4,301	N/A
5/31/2013	71,349	2,146	N/A	3,946	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que WGBA34 sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (9.8%).

Beneficios vs. Mercado: Se prevé que WGBA34 sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que WGBA34 sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.7% al año) de WGBA34 crezcan más despacio que el mercado de BR (7.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.7% al año) de WGBA34 crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de WGBA34 sea baja dentro de 3 años (19.4%).

Walgreens Boots Alliance Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

Recent updates

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023

Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc. Announces Resignation of William Foote, the Board Lead Independent Director

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into a definitive agreement to acquire remaining 45% stake in CareCentrix, Inc. for approximately $390 million.

John Standley to Leave as Executive Vice President of Walgreens Boots Alliance, Inc. on November 1, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire additional 30% stake in Shields Specialty Pharmacy Holdings, LLC from Welsh, Carson, Anderson & Stowe, Jack Shields & others for approximately $1.4 billion.

Walgreens Boots Alliance, Inc. to Report Q4, 2022 Results on Oct 13, 2022

Walgreens Boots Alliance, Inc. Announces Executive Appointments

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. Names Alethia Jackson Senior Vice President, ESG and Chief DEI Officer

Walgreens Boots Alliance, Inc. Announces Resignation of David J. Brailer as Member of the Board of Directors

Jnd Legal Administration Announces A Class Action Lawsuit in the U.S. District Court for the District of Arizona Against Defendants Theranos, Inc., Walgreens Boots Alliance, Inc. and Walgreen Arizona Drug Company

Walgreens Boots Alliance Increases Quarterly Dividend, Payable September 9, 2022

Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of Its Successful Boots Business

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Walgreens Boots Alliance, Inc. to Report Q3, 2022 Results on Jun 30, 2022

Walgreens Reportedly Gives A Few Extra Days for Bidders to Firm Up Offers

An unknown buyer acquired 2.9% stake in AmerisourceBergen Corporation (NYSE:ABC) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $900 million.

Walgreens Boots Alliance, Inc. Reaches Opioid Settlement with State of Florida

Walgreens Reportedly Sets Deadline for Bids in Boots Auction

Reliance Industries Reportedly Studying Possible Bid for Walgreens' Boots Chain

Private Equity Giant Reportedly Abandons Boots Takeover

Walgreens Boots Alliance, Inc. Appoints Steven J. Shulman to Its Board of Directors

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 11, 2022

Bain and CVC Reportedly to Team Up for Boots Bid

Oak Street Real Estate Capital, LLC acquired 1.68-acre property at 3600 Winter Garden Vineland Road in Winter Garden from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $5.2 million.

PLx Pharma Inc.’s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from Russell 1000 Defensive Index

Walgreens Boots Alliance, Inc. to Report Q2, 2021 Results on Mar 31, 2021

Walgreens and Uber Technologies, Inc. Enters into an Agreement to Help Drive Equitable Access to COVID-19 Vaccines Among Underserved Communities

Walgreens Boots Alliance, Inc Announces Management Changes Effect from March 15, 2021

Walgreens Boots Alliance Announces Executive Changes

Walgreens Expands Financial Services Business Strategy, in Partnership with Synchrony and Mastercard

Walgreens Begins Administration of Pfizer’s COVID-19 Vaccine in Long-Term Care Facilities

Verizon Business and Walgreens Boots Alliance Partner to Power Digital Customer Experiences at Walgreens Stores Nationwide

Walgreens Boots Alliance, Inc. to Report Q1, 2021 Results on Jan 07, 2021

Walgreens and VillageMD to Open the Next 40 Full-Service Primary Care Clinics

Walgreens Boots Alliance and McKesson Corporation the Formation of German Wholesale Joint Venture

Walgreens Boots Alliance, Inc. Appoints Valerie Jarrett to Its Board of Directors

Walgreens Boots Alliance, Inc. to Report Q4, 2020 Results on Oct 15, 2020

Walgreens Launches Walgreens Test & Protect Program to Aid Businesses’ COVID-19 Strategies

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción